GlassScriptPhysician profile
Joseph Palmer
NPI 1518459726
$21,318.96
in general payments reported to CMS, 2019-2025
10 companies · $5,681 in 2025
The $5,681 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $153 · 2022: $2,731 · 2023: $5,049 · 2024: $6,827 · 2025: $5,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $5,763 · Grant: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,543.39 |
| Travel and Lodging | $5,763.19 |
| Grant | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,719.39 | 2022-2025 | Mako, Pangea, Pro |
| Zimmer Biomet Holdings, INC. | $6,925.44 | 2023-2025 | Persona, Rosa, A.L.P.S. |
| Smith+Nephew, INC. | $1,977.28 | 2020-2025 | Trigen Intertan, Real Intelligence, Evos |
| Southern Edge Orthopaedics, INC. | $1,141.19 | 2019-2022 | |
| Depuy Synthes Sales INC. | $299.69 | 2024 | Actis, Motoband |
| Biocomposites INC | $86.00 | 2024 | |
| Vericel Corporation | $82.06 | 2022 | |
| Kci USA, INC. | $45.41 | 2022-2023 | Prevena |
| Innovation Technologies INC | $30.04 | 2025 | Irrisept |
| Heron Therapeutics, INC. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.